Autism comprises a growing segment of the population and can be a management challenge in the intensive care unit (ICU). We present the case of a 22-year-old male with severe autism and intellectual disorder who developed respiratory failure and required a prolonged ICU course. This patient exhibited severe distress, aggression, and self-injurious behavior. Management challenges included sedation, weaning from sedation, and liberation from mechanical ventilation. Success was achieved with a multispecialty team and by tailoring the environment and interactions to the patient’s known preferences. The use of dexmedetomidine to wean high-dose benzodiazepines and opiates also permitted successful liberation from mechanical ventilation.
Association AP. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: author;2000.
2.
MandellDSNovakMMZubritskyCD. Factors associated with age of diagnosis among children with autism spectrum disorders. Pediatrics. 2005;116(6):1480–1486.
3.
Investigators ADDMNSYP. Prevalence of autism spectrum disorders - autism and developmental disabilities monitoring network, 14 sites, United States, 2008. MMWR Surveill Summ. 2012;61(3):1–19.
4.
KingMBearmanP. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38(5):1224–1234.
5.
NassarNDixonGBourkeJ. Autism spectrum disorders in young children: effect of changes in diagnostic practices. Int J Epidemiol. 2009;38(5):1245–1254.
6.
FombonneEQuirkeSHagenA. Prevalence and interpretation of recent trends in rates of pervasive developmental disorders. Mcgill J Med. 2009;12(2):73.
7.
ScarpinatoNBradleyJKurbjunKBatemanXHoltzerBElyB. Caring for the child with an autism spectrum disorder in the acute care setting. J Spec Pediatr Nurs. 2010;15(3):244–254.
8.
TomchekSDDunnW. Sensory processing in children with and without autism: a comparative study using the short sensory profile. Am J Occup Ther. 2007;61(2):190–200.
9.
PrattKBairdGGringrasP.Ensuring successful admission to hospital for young people with learning difficulties, autism and challenging behaviour: a continuous quality improvement and change management programme. Child Care Health Dev. 2012;38(6):789–797
10.
SeidMShermanMSeidAB. Perioperative psychosocial interventions for autistic children undergoing ENT surgery. Int J Pediatr Otorhinolaryngol. 1997;40(2-3):107–113.
11.
AllisonKPSmithG. Burn management in a patient with autism. Burns. 1998;24(5):484–486.
12.
BindnerAHardinAOBerkenboschJW.Pediatric intensive care unit management and discharge of a severely autistic patient. Internet J Emerg Intensive Care Med. 2008;11(2). doi:10.5580/de0
13.
PisalchaiyongTTrairatvorakulCJirakijjaJYuktarnondaW. Comparison of the effectiveness of oral diazepam and midazolam for the sedation of autistic patients during dental treatment. Pediatr Dent. 2005;27(3):198–206.
14.
van der WaltJHMoranC. An audit of perioperative management of autistic children. Paediatr Anaesth. 2001;11(4):401–408.
15.
RossAKHazlettHCGarrettNTWilkersonCPivenJ. Moderate sedation for MRI in young children with autism. Pediatr Radiol. 2005;35(9):867–871.
16.
MehtaUCPatelICastelloFV. EEG sedation for children with autism. J Dev Behav Pediatr. 2004;25(2):102–104.
17.
RayTTobiasJD. Dexmedetomidine for sedation during electroencephalographic analysis in children with autism, pervasive developmental disorders, and seizure disorders. J Clin Anesth. 2008;20(5):364–368.
18.
LubischNRoskosRBerkenboschJW. Dexmedetomidine for procedural sedation in children with autism and other behavior disorders. Pediatr Neurol. 2009;41(2):88–94.
19.
BarrowWJJaworskiMAccardoPJ. Persistent toe walking in autism. J Child Neurol. 2011;26(5):619–621.
20.
RinehartNJBradshawJLBreretonAVTongeBJ. A clinical and neurobehavioural review of high-functioning autism and Asperger's disorder. Aust N Z J Psychiatry. 2002;36(2):762–770.
GerlachATDastaJF. Dexmedetomidine: an updated review. Ann Pharmacother. 2007;41(2):245–252.
23.
GerlachATMurphyCVDastaJF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43(12):2064–2074.
24.
RikerRRShehabiYBokeschPM. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489–499.
25.
DastaJFKane-GillSLPencinaM. A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med. 2010;38(2):497–503.
26.
PandharipandePPPunBTHerrDL. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644–2653.
27.
VennRMGroundsRM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2001;87(5):684–690.
28.
HerrDLSum-PingSTEnglandM. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth. 2003;17(5):576–84.
29.
AngerKESzumitaPMBarolettiSALabrecheMJFanikosJ. Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center. Crit Pathw Cardiol. 2010;9(4):221–226.
30.
MultzAS. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg. 2003;96(4):1054–1055.
31.
ArpinoPAKalafatasKThompsonBT. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit. J Clin Pharm Ther. 2008;33(1):25–30.
32.
TobiasJD. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children. J Opioid Manag. 2008;4(4):187–191.
33.
OschmanAMcCabeTKuhnRJ. Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients. Am J Health Syst Pharm. 2011;68(13):1233–1238.
